nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurandrenolide—NR3C1—Fluoxymesterone—breast cancer	0.291	1	CbGbCtD
Flurandrenolide—Medroxyprogesterone Acetate—Fluoxymesterone—breast cancer	0.073	0.125	CrCrCtD
Flurandrenolide—Methylprednisolone—Exemestane—breast cancer	0.0695	0.119	CrCrCtD
Flurandrenolide—Prednisolone—Exemestane—breast cancer	0.068	0.117	CrCrCtD
Flurandrenolide—Hydrocortamate—Fluoxymesterone—breast cancer	0.0659	0.113	CrCrCtD
Flurandrenolide—Amcinonide—Fluoxymesterone—breast cancer	0.057	0.0979	CrCrCtD
Flurandrenolide—Fludrocortisone—Fluoxymesterone—breast cancer	0.0555	0.0953	CrCrCtD
Flurandrenolide—Dexamethasone—Fluoxymesterone—breast cancer	0.0504	0.0865	CrCrCtD
Flurandrenolide—Betamethasone—Fluoxymesterone—breast cancer	0.0504	0.0865	CrCrCtD
Flurandrenolide—Prednisolone—Fluoxymesterone—breast cancer	0.0472	0.081	CrCrCtD
Flurandrenolide—Hydrocortisone—Fluoxymesterone—breast cancer	0.0453	0.0777	CrCrCtD
Flurandrenolide—Hypertrichosis—Exemestane—breast cancer	0.00467	0.0731	CcSEcCtD
Flurandrenolide—Skin discolouration—Toremifene—breast cancer	0.00224	0.035	CcSEcCtD
Flurandrenolide—Allergic contact dermatitis—Fluorouracil—breast cancer	0.00209	0.0327	CcSEcCtD
Flurandrenolide—Leukoderma—Thiotepa—breast cancer	0.00208	0.0325	CcSEcCtD
Flurandrenolide—Secondary infection—Epirubicin—breast cancer	0.00121	0.0189	CcSEcCtD
Flurandrenolide—Eruption—Gemcitabine—breast cancer	0.00121	0.0189	CcSEcCtD
Flurandrenolide—Skin discolouration—Goserelin—breast cancer	0.00114	0.0179	CcSEcCtD
Flurandrenolide—Secondary infection—Doxorubicin—breast cancer	0.00112	0.0175	CcSEcCtD
Flurandrenolide—Folliculitis—Paclitaxel—breast cancer	0.000989	0.0155	CcSEcCtD
Flurandrenolide—Skin discolouration—Thiotepa—breast cancer	0.000977	0.0153	CcSEcCtD
Flurandrenolide—Leukoderma—Methotrexate—breast cancer	0.000893	0.014	CcSEcCtD
Flurandrenolide—Dermatitis contact—Thiotepa—breast cancer	0.000872	0.0137	CcSEcCtD
Flurandrenolide—Eruption—Docetaxel—breast cancer	0.000857	0.0134	CcSEcCtD
Flurandrenolide—Infection—Carboplatin—breast cancer	0.000836	0.0131	CcSEcCtD
Flurandrenolide—Leukoderma—Epirubicin—breast cancer	0.000836	0.0131	CcSEcCtD
Flurandrenolide—Hypersensitivity—Fluoxymesterone—breast cancer	0.000824	0.0129	CcSEcCtD
Flurandrenolide—Infection—Lapatinib—breast cancer	0.000788	0.0123	CcSEcCtD
Flurandrenolide—Leukoderma—Doxorubicin—breast cancer	0.000774	0.0121	CcSEcCtD
Flurandrenolide—Infection—Fulvestrant—breast cancer	0.000725	0.0113	CcSEcCtD
Flurandrenolide—Dermatitis contact—Fluorouracil—breast cancer	0.000721	0.0113	CcSEcCtD
Flurandrenolide—Skin discolouration—Paclitaxel—breast cancer	0.000688	0.0108	CcSEcCtD
Flurandrenolide—Infection—Exemestane—breast cancer	0.00063	0.00986	CcSEcCtD
Flurandrenolide—Eruption—Methotrexate—breast cancer	0.000617	0.00966	CcSEcCtD
Flurandrenolide—Folliculitis—Methotrexate—breast cancer	0.000604	0.00945	CcSEcCtD
Flurandrenolide—SERPINA6—pituitary gland—breast cancer	0.000604	0.0919	CbGeAlD
Flurandrenolide—Infection—Ixabepilone—breast cancer	0.000594	0.0093	CcSEcCtD
Flurandrenolide—Hypersensitivity—Lapatinib—breast cancer	0.000585	0.00915	CcSEcCtD
Flurandrenolide—Eruption—Epirubicin—breast cancer	0.000578	0.00904	CcSEcCtD
Flurandrenolide—Folliculitis—Epirubicin—breast cancer	0.000565	0.00885	CcSEcCtD
Flurandrenolide—Skin discolouration—Capecitabine—breast cancer	0.000565	0.00884	CcSEcCtD
Flurandrenolide—Pruritus—Lapatinib—breast cancer	0.000561	0.00879	CcSEcCtD
Flurandrenolide—Infection—Letrozole—breast cancer	0.00056	0.00876	CcSEcCtD
Flurandrenolide—Infection—Anastrozole—breast cancer	0.00056	0.00876	CcSEcCtD
Flurandrenolide—SERPINA6—female reproductive system—breast cancer	0.000553	0.0841	CbGeAlD
Flurandrenolide—SERPINA6—adrenal gland—breast cancer	0.000539	0.0821	CbGeAlD
Flurandrenolide—Hypersensitivity—Fulvestrant—breast cancer	0.000538	0.00841	CcSEcCtD
Flurandrenolide—Eruption—Doxorubicin—breast cancer	0.000535	0.00837	CcSEcCtD
Flurandrenolide—Infection—Raloxifene—breast cancer	0.000531	0.00831	CcSEcCtD
Flurandrenolide—Infection—Idarubicin—breast cancer	0.000531	0.00831	CcSEcCtD
Flurandrenolide—Folliculitis—Doxorubicin—breast cancer	0.000523	0.00819	CcSEcCtD
Flurandrenolide—SERPINA6—bone marrow—breast cancer	0.000522	0.0794	CbGeAlD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—AFP—breast cancer	0.000521	0.0101	CbGpPWpGaD
Flurandrenolide—Pruritus—Fulvestrant—breast cancer	0.000516	0.00808	CcSEcCtD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—RXRB—breast cancer	0.000512	0.00993	CbGpPWpGaD
Flurandrenolide—Pruritus—Toremifene—breast cancer	0.00051	0.00798	CcSEcCtD
Flurandrenolide—Rash—Lapatinib—breast cancer	0.0005	0.00783	CcSEcCtD
Flurandrenolide—Dermatitis—Lapatinib—breast cancer	0.0005	0.00782	CcSEcCtD
Flurandrenolide—NR3C1—nipple—breast cancer	0.000484	0.0737	CbGeAlD
Flurandrenolide—NR3C1—Nuclear Receptors—RARB—breast cancer	0.000483	0.00937	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—KRT5—breast cancer	0.000476	0.00924	CbGpPWpGaD
Flurandrenolide—SERPINA6—endocrine gland—breast cancer	0.000468	0.0712	CbGeAlD
Flurandrenolide—Hypersensitivity—Exemestane—breast cancer	0.000467	0.00731	CcSEcCtD
Flurandrenolide—Rash—Fulvestrant—breast cancer	0.00046	0.0072	CcSEcCtD
Flurandrenolide—Dermatitis—Fulvestrant—breast cancer	0.00046	0.00719	CcSEcCtD
Flurandrenolide—Rash—Toremifene—breast cancer	0.000454	0.00711	CcSEcCtD
Flurandrenolide—Dermatitis—Toremifene—breast cancer	0.000454	0.0071	CcSEcCtD
Flurandrenolide—Fluocinolone Acetonide—PLA2G4A—breast cancer	0.000452	0.0917	CrCbGaD
Flurandrenolide—Pruritus—Exemestane—breast cancer	0.000448	0.00702	CcSEcCtD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—KRT14—breast cancer	0.000443	0.00859	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Ixabepilone—breast cancer	0.000441	0.0069	CcSEcCtD
Flurandrenolide—NR3C1—Adipogenesis—NR2F1—breast cancer	0.000435	0.00843	CbGpPWpGaD
Flurandrenolide—Infection—Chlorambucil—breast cancer	0.00043	0.00673	CcSEcCtD
Flurandrenolide—Pruritus—Ixabepilone—breast cancer	0.000423	0.00662	CcSEcCtD
Flurandrenolide—Skin discolouration—Methotrexate—breast cancer	0.00042	0.00658	CcSEcCtD
Flurandrenolide—Hypersensitivity—Anastrozole—breast cancer	0.000415	0.00649	CcSEcCtD
Flurandrenolide—NR3C1—Adipogenesis—EBF1—breast cancer	0.000404	0.00784	CbGpPWpGaD
Flurandrenolide—Rash—Exemestane—breast cancer	0.0004	0.00625	CcSEcCtD
Flurandrenolide—NR3C1—embryo—breast cancer	0.000399	0.0608	CbGeAlD
Flurandrenolide—Dermatitis—Exemestane—breast cancer	0.000399	0.00625	CcSEcCtD
Flurandrenolide—Pruritus—Anastrozole—breast cancer	0.000398	0.00624	CcSEcCtD
Flurandrenolide—Pruritus—Letrozole—breast cancer	0.000398	0.00624	CcSEcCtD
Flurandrenolide—Hypersensitivity—Idarubicin—breast cancer	0.000394	0.00616	CcSEcCtD
Flurandrenolide—Skin discolouration—Epirubicin—breast cancer	0.000393	0.00616	CcSEcCtD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—SLC2A2—breast cancer	0.000391	0.00758	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptors—PGR—breast cancer	0.000384	0.00744	CbGpPWpGaD
Flurandrenolide—Infection—Tamoxifen—breast cancer	0.000383	0.00599	CcSEcCtD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1A—breast cancer	0.000383	0.00743	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—RARB—breast cancer	0.000382	0.0074	CbGpPWpGaD
Flurandrenolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA2—breast cancer	0.000377	0.00732	CbGpPWpGaD
Flurandrenolide—Rash—Ixabepilone—breast cancer	0.000377	0.0059	CcSEcCtD
Flurandrenolide—Dermatitis—Ixabepilone—breast cancer	0.000377	0.0059	CcSEcCtD
Flurandrenolide—Infection—Melphalan—breast cancer	0.000375	0.00587	CcSEcCtD
Flurandrenolide—Infection—Goserelin—breast cancer	0.000366	0.00572	CcSEcCtD
Flurandrenolide—Skin discolouration—Doxorubicin—breast cancer	0.000364	0.0057	CcSEcCtD
Flurandrenolide—Rash—Anastrozole—breast cancer	0.000355	0.00556	CcSEcCtD
Flurandrenolide—Rash—Letrozole—breast cancer	0.000355	0.00556	CcSEcCtD
Flurandrenolide—Dermatitis—Letrozole—breast cancer	0.000355	0.00555	CcSEcCtD
Flurandrenolide—Dermatitis—Anastrozole—breast cancer	0.000355	0.00555	CcSEcCtD
Flurandrenolide—Dermatitis contact—Epirubicin—breast cancer	0.000351	0.0055	CcSEcCtD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—DLX2—breast cancer	0.000349	0.00678	CbGpPWpGaD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—breast cancer	0.000341	0.00662	CbGpPWpGaD
Flurandrenolide—NR3C1—Endoderm Differentiation—PABPC1—breast cancer	0.000339	0.00658	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptors—ESR2—breast cancer	0.000338	0.00655	CbGpPWpGaD
Flurandrenolide—Rash—Idarubicin—breast cancer	0.000337	0.00527	CcSEcCtD
Flurandrenolide—Rash—Raloxifene—breast cancer	0.000337	0.00527	CcSEcCtD
Flurandrenolide—Dermatitis—Raloxifene—breast cancer	0.000337	0.00527	CcSEcCtD
Flurandrenolide—Dermatitis—Idarubicin—breast cancer	0.000337	0.00527	CcSEcCtD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—LEP—breast cancer	0.000332	0.00645	CbGpPWpGaD
Flurandrenolide—Infection—Vinorelbine—breast cancer	0.000328	0.00513	CcSEcCtD
Flurandrenolide—NR3C1—epithelium—breast cancer	0.000326	0.0496	CbGeAlD
Flurandrenolide—Dermatitis contact—Doxorubicin—breast cancer	0.000325	0.00509	CcSEcCtD
Flurandrenolide—NR3C1—Circadian Clock—CPT1A—breast cancer	0.00032	0.00621	CbGpPWpGaD
Flurandrenolide—NR3C1—Signaling events mediated by HDAC Class II—HSP90AA1—breast cancer	0.00032	0.00621	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Chlorambucil—breast cancer	0.000319	0.00499	CcSEcCtD
Flurandrenolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA1—breast cancer	0.000318	0.00617	CbGpPWpGaD
Flurandrenolide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—breast cancer	0.000317	0.00615	CbGpPWpGaD
Flurandrenolide—Infection—Thiotepa—breast cancer	0.000313	0.0049	CcSEcCtD
Flurandrenolide—NR3C1—skin of body—breast cancer	0.00031	0.0472	CbGeAlD
Flurandrenolide—Drospirenone—PGR—breast cancer	0.000309	0.0627	CrCbGaD
Flurandrenolide—Pruritus—Chlorambucil—breast cancer	0.000306	0.00479	CcSEcCtD
Flurandrenolide—NR3C1—Adipogenesis—TWIST1—breast cancer	0.000306	0.00594	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—PGR—breast cancer	0.000303	0.00588	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptors—AR—breast cancer	0.000298	0.00579	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Vinblastine—breast cancer	0.000292	0.00457	CcSEcCtD
Flurandrenolide—NR3C1—endometrium—breast cancer	0.000292	0.0445	CbGeAlD
Flurandrenolide—NR3C1—Endoderm Differentiation—DKK1—breast cancer	0.000288	0.00559	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Tamoxifen—breast cancer	0.000284	0.00444	CcSEcCtD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—NCOA2—breast cancer	0.000283	0.00549	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—WNT10B—breast cancer	0.00028	0.00543	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Melphalan—breast cancer	0.000278	0.00435	CcSEcCtD
Flurandrenolide—NR3C1—Circadian Clock—NCOA2—breast cancer	0.000275	0.00533	CbGpPWpGaD
Flurandrenolide—Pruritus—Tamoxifen—breast cancer	0.000273	0.00427	CcSEcCtD
Flurandrenolide—Hypersensitivity—Goserelin—breast cancer	0.000271	0.00424	CcSEcCtD
Flurandrenolide—Infection—Irinotecan—breast cancer	0.00027	0.00423	CcSEcCtD
Flurandrenolide—Infection—Mitoxantrone—breast cancer	0.00027	0.00423	CcSEcCtD
Flurandrenolide—NR3C1—uterus—breast cancer	0.000269	0.041	CbGeAlD
Flurandrenolide—NR3C1—Nuclear Receptors—VDR—breast cancer	0.000268	0.0052	CbGpPWpGaD
Flurandrenolide—Pruritus—Melphalan—breast cancer	0.000267	0.00418	CcSEcCtD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—ESR2—breast cancer	0.000267	0.00518	CbGpPWpGaD
Flurandrenolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—breast cancer	0.000266	0.00517	CbGpPWpGaD
Flurandrenolide—NR3C1—pituitary gland—breast cancer	0.000264	0.0403	CbGeAlD
Flurandrenolide—NR3C1—adipose tissue—breast cancer	0.000263	0.0401	CbGeAlD
Flurandrenolide—Infection—Gemcitabine—breast cancer	0.000263	0.00412	CcSEcCtD
Flurandrenolide—Pruritus—Goserelin—breast cancer	0.00026	0.00408	CcSEcCtD
Flurandrenolide—NR3C1—Adipogenesis—NRIP1—breast cancer	0.00026	0.00505	CbGpPWpGaD
Flurandrenolide—Infection—Fluorouracil—breast cancer	0.000259	0.00405	CcSEcCtD
Flurandrenolide—Drospirenone—AR—breast cancer	0.000253	0.0514	CrCbGaD
Flurandrenolide—NR3C1—Endoderm Differentiation—PTHLH—breast cancer	0.000251	0.00487	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—HSP90AA1—breast cancer	0.000245	0.00476	CbGpPWpGaD
Flurandrenolide—Rash—Tamoxifen—breast cancer	0.000243	0.0038	CcSEcCtD
Flurandrenolide—Hypersensitivity—Vinorelbine—breast cancer	0.000243	0.0038	CcSEcCtD
Flurandrenolide—Dermatitis—Tamoxifen—breast cancer	0.000243	0.0038	CcSEcCtD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—EGR1—breast cancer	0.000242	0.0047	CbGpPWpGaD
Flurandrenolide—NR3C1—female reproductive system—breast cancer	0.000242	0.0369	CbGeAlD
Flurandrenolide—NR3C1—Adipogenesis—MIF—breast cancer	0.00024	0.00466	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—PRLR—breast cancer	0.00024	0.00466	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—NCOA1—breast cancer	0.000238	0.00463	CbGpPWpGaD
Flurandrenolide—Fludrocortisone—AR—breast cancer	0.000238	0.0484	CrCbGaD
Flurandrenolide—Rash—Melphalan—breast cancer	0.000238	0.00372	CcSEcCtD
Flurandrenolide—Dermatitis—Melphalan—breast cancer	0.000238	0.00372	CcSEcCtD
Flurandrenolide—NR3C1—adrenal gland—breast cancer	0.000236	0.036	CbGeAlD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—YBX1—breast cancer	0.000236	0.00458	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—HADHB—breast cancer	0.000236	0.00458	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—AR—breast cancer	0.000236	0.00457	CbGpPWpGaD
Flurandrenolide—Pruritus—Vinorelbine—breast cancer	0.000233	0.00365	CcSEcCtD
Flurandrenolide—Rash—Goserelin—breast cancer	0.000232	0.00363	CcSEcCtD
Flurandrenolide—Hypersensitivity—Thiotepa—breast cancer	0.000232	0.00363	CcSEcCtD
Flurandrenolide—Dermatitis—Goserelin—breast cancer	0.000232	0.00363	CcSEcCtD
Flurandrenolide—NR3C1—Circadian Clock—NCOA1—breast cancer	0.000232	0.00449	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—ZNF432—breast cancer	0.000229	0.00444	CbGpPWpGaD
Flurandrenolide—NR3C1—Endoderm Differentiation—EZH2—breast cancer	0.000229	0.00444	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—AR—breast cancer	0.000229	0.00444	CbGpPWpGaD
Flurandrenolide—NR3C1—bone marrow—breast cancer	0.000229	0.0348	CbGeAlD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—breast cancer	0.000228	0.00443	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—THRB—breast cancer	0.000225	0.00437	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—DDIT3—breast cancer	0.000225	0.00436	CbGpPWpGaD
Flurandrenolide—Pruritus—Thiotepa—breast cancer	0.000223	0.00349	CcSEcCtD
Flurandrenolide—Infection—Paclitaxel—breast cancer	0.00022	0.00345	CcSEcCtD
Flurandrenolide—NR3C1—female gonad—breast cancer	0.00022	0.0335	CbGeAlD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—VDR—breast cancer	0.000212	0.00411	CbGpPWpGaD
Flurandrenolide—Drospirenone—BCHE—breast cancer	0.000211	0.0429	CrCbGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—SIRT1—breast cancer	0.000208	0.00404	CbGpPWpGaD
Flurandrenolide—Rash—Vinorelbine—breast cancer	0.000208	0.00325	CcSEcCtD
Flurandrenolide—Dermatitis—Vinorelbine—breast cancer	0.000208	0.00325	CcSEcCtD
Flurandrenolide—Medroxyprogesterone Acetate—PGR—breast cancer	0.000206	0.0418	CrCbGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—breast cancer	0.000205	0.00398	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptors—ESR1—breast cancer	0.000205	0.00397	CbGpPWpGaD
Flurandrenolide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—breast cancer	0.000205	0.00397	CbGpPWpGaD
Flurandrenolide—NR3C1—endocrine gland—breast cancer	0.000205	0.0312	CbGeAlD
Flurandrenolide—NR3C1—AP-1 transcription factor network—TCF7L2—breast cancer	0.000204	0.00395	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—GATA3—breast cancer	0.000203	0.00394	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA2—breast cancer	0.000202	0.00391	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Mitoxantrone—breast cancer	0.0002	0.00314	CcSEcCtD
Flurandrenolide—Hypersensitivity—Irinotecan—breast cancer	0.0002	0.00314	CcSEcCtD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—NCOA2—breast cancer	0.0002	0.00387	CbGpPWpGaD
Flurandrenolide—Rash—Thiotepa—breast cancer	0.000199	0.00311	CcSEcCtD
Flurandrenolide—Dermatitis—Thiotepa—breast cancer	0.000198	0.0031	CcSEcCtD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—PPARGC1B—breast cancer	0.000194	0.00377	CbGpPWpGaD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—breast cancer	0.000194	0.00377	CbGpPWpGaD
Flurandrenolide—NR3C1—Circadian Clock—NCOR1—breast cancer	0.000194	0.00376	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—EGR1—breast cancer	0.000194	0.00376	CbGpPWpGaD
Flurandrenolide—Medroxyprogesterone Acetate—SHBG—breast cancer	0.000193	0.0391	CrCbGaD
Flurandrenolide—Hypersensitivity—Fluorouracil—breast cancer	0.000192	0.003	CcSEcCtD
Flurandrenolide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—breast cancer	0.000191	0.0037	CbGpPWpGaD
Flurandrenolide—Pruritus—Gemcitabine—breast cancer	0.000187	0.00293	CcSEcCtD
Flurandrenolide—Betamethasone—PGR—breast cancer	0.000187	0.038	CrCbGaD
Flurandrenolide—Infection—Docetaxel—breast cancer	0.000187	0.00292	CcSEcCtD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—breast cancer	0.000184	0.00358	CbGpPWpGaD
Flurandrenolide—Pruritus—Fluorouracil—breast cancer	0.000184	0.00288	CcSEcCtD
Flurandrenolide—Infection—Capecitabine—breast cancer	0.000181	0.00283	CcSEcCtD
Flurandrenolide—NR3C1—Adipogenesis—AHR—breast cancer	0.000181	0.0035	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—breast cancer	0.000173	0.00335	CbGpPWpGaD
Flurandrenolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—breast cancer	0.000172	0.00334	CbGpPWpGaD
Flurandrenolide—Rash—Mitoxantrone—breast cancer	0.000171	0.00268	CcSEcCtD
Flurandrenolide—Rash—Irinotecan—breast cancer	0.000171	0.00268	CcSEcCtD
Flurandrenolide—Dermatitis—Mitoxantrone—breast cancer	0.000171	0.00268	CcSEcCtD
Flurandrenolide—Dermatitis—Irinotecan—breast cancer	0.000171	0.00268	CcSEcCtD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—EGR1—breast cancer	0.000171	0.00331	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA1—breast cancer	0.00017	0.0033	CbGpPWpGaD
Flurandrenolide—Medroxyprogesterone Acetate—AR—breast cancer	0.000169	0.0343	CrCbGaD
Flurandrenolide—NR3C1—Endoderm Differentiation—SMAD4—breast cancer	0.000169	0.00327	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—PRL—breast cancer	0.000168	0.00326	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—NCOA1—breast cancer	0.000168	0.00326	CbGpPWpGaD
Flurandrenolide—Rash—Gemcitabine—breast cancer	0.000167	0.00261	CcSEcCtD
Flurandrenolide—Dermatitis—Gemcitabine—breast cancer	0.000167	0.00261	CcSEcCtD
Flurandrenolide—NR3C1—Adipogenesis—WNT1—breast cancer	0.000165	0.00321	CbGpPWpGaD
Flurandrenolide—Rash—Fluorouracil—breast cancer	0.000164	0.00257	CcSEcCtD
Flurandrenolide—Dermatitis—Fluorouracil—breast cancer	0.000164	0.00257	CcSEcCtD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—FOXM1—breast cancer	0.000164	0.00317	CbGpPWpGaD
Flurandrenolide—NR3C1—Circadian Clock—HIF1A—breast cancer	0.000164	0.00317	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Paclitaxel—breast cancer	0.000163	0.00256	CcSEcCtD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—breast cancer	0.000163	0.00316	CbGpPWpGaD
Flurandrenolide—NR3C1—Nuclear Receptor transcription pathway—ESR1—breast cancer	0.000162	0.00314	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—BMP4—breast cancer	0.000161	0.00312	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NR2F1—breast cancer	0.000159	0.00308	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—CSF2—breast cancer	0.000158	0.00307	CbGpPWpGaD
Flurandrenolide—Pruritus—Paclitaxel—breast cancer	0.000157	0.00246	CcSEcCtD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—TNF—breast cancer	0.000154	0.00298	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—breast cancer	0.00015	0.00291	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—BMP2—breast cancer	0.00015	0.0029	CbGpPWpGaD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—breast cancer	0.000149	0.0029	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NR2F6—breast cancer	0.000148	0.00286	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—HNF4G—breast cancer	0.000148	0.00286	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—ALDOA—breast cancer	0.000147	0.00286	CbGpPWpGaD
Flurandrenolide—Dexamethasone—CYP17A1—breast cancer	0.000147	0.0298	CrCbGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—breast cancer	0.000147	0.00284	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—breast cancer	0.000146	0.00284	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—breast cancer	0.000142	0.00276	CbGpPWpGaD
Flurandrenolide—NR3C1—lymph node—breast cancer	0.000142	0.0216	CbGeAlD
Flurandrenolide—NR3C1—Adipogenesis—GATA3—breast cancer	0.000141	0.00273	CbGpPWpGaD
Flurandrenolide—Rash—Paclitaxel—breast cancer	0.00014	0.00219	CcSEcCtD
Flurandrenolide—Dermatitis—Paclitaxel—breast cancer	0.00014	0.00219	CcSEcCtD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—CSF2—breast cancer	0.000139	0.0027	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—CPT1A—breast cancer	0.000139	0.0027	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Docetaxel—breast cancer	0.000138	0.00217	CcSEcCtD
Flurandrenolide—NR3C1—Adipogenesis—NCOA2—breast cancer	0.000138	0.00268	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—BAX—breast cancer	0.000137	0.00266	CbGpPWpGaD
Flurandrenolide—Hydrocortisone—SHBG—breast cancer	0.000137	0.0277	CrCbGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—MMP1—breast cancer	0.000136	0.00264	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—HIF1A—breast cancer	0.000135	0.00262	CbGpPWpGaD
Flurandrenolide—Infection—Methotrexate—breast cancer	0.000135	0.00211	CcSEcCtD
Flurandrenolide—Hypersensitivity—Capecitabine—breast cancer	0.000134	0.0021	CcSEcCtD
Flurandrenolide—NR3C1—AP-1 transcription factor network—PLAU—breast cancer	0.000134	0.00259	CbGpPWpGaD
Flurandrenolide—Pruritus—Docetaxel—breast cancer	0.000133	0.00208	CcSEcCtD
Flurandrenolide—Medroxyprogesterone Acetate—ESR1—breast cancer	0.00013	0.0264	CrCbGaD
Flurandrenolide—Pruritus—Capecitabine—breast cancer	0.000129	0.00202	CcSEcCtD
Flurandrenolide—Betamethasone—CYP19A1—breast cancer	0.000128	0.0261	CrCbGaD
Flurandrenolide—Infection—Epirubicin—breast cancer	0.000126	0.00197	CcSEcCtD
Flurandrenolide—NR3C1—AP-1 transcription factor network—ESR1—breast cancer	0.000126	0.00244	CbGpPWpGaD
Flurandrenolide—NR3C1—Circadian Clock—SERPINE1—breast cancer	0.000125	0.00243	CbGpPWpGaD
Flurandrenolide—NR3C1—Endoderm Differentiation—NOTCH1—breast cancer	0.000124	0.00241	CbGpPWpGaD
Flurandrenolide—NR3C1—Transcription factor regulation in adipogenesis—IL6—breast cancer	0.000124	0.00241	CbGpPWpGaD
Flurandrenolide—NR3C1—Endoderm Differentiation—APC—breast cancer	0.000122	0.00236	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—GATA3—breast cancer	0.000122	0.00236	CbGpPWpGaD
Flurandrenolide—Hydrocortamate—CYP3A4—breast cancer	0.00012	0.0244	CrCbGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—breast cancer	0.00012	0.00232	CbGpPWpGaD
Flurandrenolide—Dexamethasone—NOS2—breast cancer	0.00012	0.0243	CrCbGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—breast cancer	0.000119	0.0023	CbGpPWpGaD
Flurandrenolide—Rash—Docetaxel—breast cancer	0.000119	0.00185	CcSEcCtD
Flurandrenolide—Dermatitis—Docetaxel—breast cancer	0.000118	0.00185	CcSEcCtD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—MDM2—breast cancer	0.000117	0.00227	CbGpPWpGaD
Flurandrenolide—Infection—Doxorubicin—breast cancer	0.000117	0.00182	CcSEcCtD
Flurandrenolide—NR3C1—Adipogenesis—NCOA1—breast cancer	0.000116	0.00226	CbGpPWpGaD
Flurandrenolide—Rash—Capecitabine—breast cancer	0.000115	0.0018	CcSEcCtD
Flurandrenolide—Dermatitis—Capecitabine—breast cancer	0.000115	0.00179	CcSEcCtD
Flurandrenolide—NR3C1—AP-1 transcription factor network—FOS—breast cancer	0.000113	0.0022	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—breast cancer	0.000112	0.00218	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—breast cancer	0.000112	0.00217	CbGpPWpGaD
Flurandrenolide—Budesonide—CYP3A4—breast cancer	0.000112	0.0227	CrCbGaD
Flurandrenolide—NR3C1—Gene Expression—ZNF432—breast cancer	0.00011	0.00214	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—ESR2—breast cancer	0.000109	0.00212	CbGpPWpGaD
Flurandrenolide—Dexamethasone—PGR—breast cancer	0.000109	0.0221	CrCbGaD
Flurandrenolide—Ciclesonide—CYP2D6—breast cancer	0.000106	0.0215	CrCbGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—ESRRA—breast cancer	0.000105	0.00204	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—STAT5A—breast cancer	0.000104	0.00201	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—EGR1—breast cancer	0.000102	0.00198	CbGpPWpGaD
Flurandrenolide—Dexamethasone—CYP1B1—breast cancer	0.000102	0.0206	CrCbGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—JUN—breast cancer	0.000102	0.00197	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—breast cancer	0.000101	0.00195	CbGpPWpGaD
Flurandrenolide—Hypersensitivity—Methotrexate—breast cancer	9.98e-05	0.00156	CcSEcCtD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—FOS—breast cancer	9.98e-05	0.00194	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—NCOR1—breast cancer	9.75e-05	0.00189	CbGpPWpGaD
Flurandrenolide—Drospirenone—PTGS2—breast cancer	9.74e-05	0.0198	CrCbGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—AR—breast cancer	9.64e-05	0.00187	CbGpPWpGaD
Flurandrenolide—Alclometasone—CYP3A4—breast cancer	9.62e-05	0.0195	CrCbGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—MAPK8—breast cancer	9.61e-05	0.00186	CbGpPWpGaD
Flurandrenolide—Pruritus—Methotrexate—breast cancer	9.59e-05	0.0015	CcSEcCtD
Flurandrenolide—NR3C1—Generic Transcription Pathway—THRB—breast cancer	9.51e-05	0.00184	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—E2F1—breast cancer	9.43e-05	0.00183	CbGpPWpGaD
Flurandrenolide—Hydrocortisone—ABCG2—breast cancer	9.41e-05	0.0191	CrCbGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—IFNG—breast cancer	9.41e-05	0.00182	CbGpPWpGaD
Flurandrenolide—Flunisolide—CYP3A4—breast cancer	9.37e-05	0.019	CrCbGaD
Flurandrenolide—Hypersensitivity—Epirubicin—breast cancer	9.34e-05	0.00146	CcSEcCtD
Flurandrenolide—Paramethasone—CYP3A4—breast cancer	9.25e-05	0.0188	CrCbGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—breast cancer	9.19e-05	0.00178	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—RXRB—breast cancer	9.12e-05	0.00177	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of Androgen receptor activity—SRC—breast cancer	9.11e-05	0.00177	CbGpPWpGaD
Flurandrenolide—Ciclesonide—CYP3A4—breast cancer	9.1e-05	0.0185	CrCbGaD
Flurandrenolide—Pruritus—Epirubicin—breast cancer	8.97e-05	0.0014	CcSEcCtD
Flurandrenolide—NR3C1—AP-1 transcription factor network—CXCL8—breast cancer	8.75e-05	0.0017	CbGpPWpGaD
Flurandrenolide—Methylprednisolone—CYP3A4—breast cancer	8.73e-05	0.0177	CrCbGaD
Flurandrenolide—Hypersensitivity—Doxorubicin—breast cancer	8.64e-05	0.00135	CcSEcCtD
Flurandrenolide—Rash—Methotrexate—breast cancer	8.54e-05	0.00134	CcSEcCtD
Flurandrenolide—NR3C1—AP-1 transcription factor network—CDKN1B—breast cancer	8.54e-05	0.00166	CbGpPWpGaD
Flurandrenolide—Dermatitis—Methotrexate—breast cancer	8.53e-05	0.00134	CcSEcCtD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—HES1—breast cancer	8.47e-05	0.00164	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—IL2—breast cancer	8.36e-05	0.00162	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—HNRNPK—breast cancer	8.36e-05	0.00162	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—HNRNPR—breast cancer	8.36e-05	0.00162	CbGpPWpGaD
Flurandrenolide—Pruritus—Doxorubicin—breast cancer	8.3e-05	0.0013	CcSEcCtD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—breast cancer	8.29e-05	0.00161	CbGpPWpGaD
Flurandrenolide—NR3C1—Endoderm Differentiation—CTNNB1—breast cancer	8.26e-05	0.0016	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—breast cancer	8.24e-05	0.0016	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—HIF1A—breast cancer	8.22e-05	0.00159	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—RELA—breast cancer	8.18e-05	0.00159	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—CCND1—breast cancer	8.15e-05	0.00158	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—JUN—breast cancer	8.13e-05	0.00158	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—CTNNB1—breast cancer	8.07e-05	0.00157	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—LEP—breast cancer	8.02e-05	0.00156	CbGpPWpGaD
Flurandrenolide—Rash—Epirubicin—breast cancer	7.99e-05	0.00125	CcSEcCtD
Flurandrenolide—Dermatitis—Epirubicin—breast cancer	7.99e-05	0.00125	CcSEcCtD
Flurandrenolide—NR3C1—AP-1 transcription factor network—MMP9—breast cancer	7.91e-05	0.00153	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—PTEN—breast cancer	7.86e-05	0.00153	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—breast cancer	7.71e-05	0.0015	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—EEF1B2—breast cancer	7.64e-05	0.00148	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—NR2F1—breast cancer	7.64e-05	0.00148	CbGpPWpGaD
Flurandrenolide—Dexamethasone—CYP19A1—breast cancer	7.47e-05	0.0152	CrCbGaD
Flurandrenolide—Rash—Doxorubicin—breast cancer	7.4e-05	0.00116	CcSEcCtD
Flurandrenolide—Dermatitis—Doxorubicin—breast cancer	7.39e-05	0.00116	CcSEcCtD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—IL2—breast cancer	7.37e-05	0.00143	CbGpPWpGaD
Flurandrenolide—Methylprednisolone—ABCB1—breast cancer	7.27e-05	0.0147	CrCbGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—breast cancer	7.24e-05	0.0014	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—JUN—breast cancer	7.16e-05	0.00139	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—HNF4G—breast cancer	7.11e-05	0.00138	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—NR2F6—breast cancer	7.11e-05	0.00138	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—HIF1A—breast cancer	7.1e-05	0.00138	CbGpPWpGaD
Flurandrenolide—Dexamethasone—ABCG2—breast cancer	7.01e-05	0.0142	CrCbGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—breast cancer	7.01e-05	0.00136	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—breast cancer	6.95e-05	0.00135	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—breast cancer	6.78e-05	0.00132	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—RB1—breast cancer	6.69e-05	0.0013	CbGpPWpGaD
Flurandrenolide—NR3C1—Endoderm Differentiation—TGFB1—breast cancer	6.67e-05	0.00129	CbGpPWpGaD
Flurandrenolide—Medroxyprogesterone Acetate—CYP3A4—breast cancer	6.64e-05	0.0135	CrCbGaD
Flurandrenolide—NR3C1—Adipogenesis—IGF1—breast cancer	6.63e-05	0.00129	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—RARB—breast cancer	6.59e-05	0.00128	CbGpPWpGaD
Flurandrenolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	6.57e-05	0.00127	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—MYC—breast cancer	6.54e-05	0.00127	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—TGFB1—breast cancer	6.52e-05	0.00126	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—HNRNPL—breast cancer	6.33e-05	0.00123	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—MED12—breast cancer	6.32e-05	0.00123	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—SERPINE1—breast cancer	6.29e-05	0.00122	CbGpPWpGaD
Flurandrenolide—Prednisolone—CYP3A4—breast cancer	6.15e-05	0.0125	CrCbGaD
Flurandrenolide—Betamethasone—CYP3A4—breast cancer	6.03e-05	0.0122	CrCbGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—breast cancer	5.92e-05	0.00115	CbGpPWpGaD
Flurandrenolide—Betamethasone—PTGS2—breast cancer	5.9e-05	0.012	CrCbGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—breast cancer	5.82e-05	0.00113	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NOTCH4—breast cancer	5.73e-05	0.00111	CbGpPWpGaD
Flurandrenolide—Dexamethasone—CYP1A1—breast cancer	5.49e-05	0.0111	CrCbGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—TP53—breast cancer	5.37e-05	0.00104	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—PGR—breast cancer	5.24e-05	0.00102	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—EIF2S2—breast cancer	5.22e-05	0.00101	CbGpPWpGaD
Flurandrenolide—Prednisolone—ABCB1—breast cancer	5.12e-05	0.0104	CrCbGaD
Flurandrenolide—NR3C1—Gene Expression—ESRRA—breast cancer	5.06e-05	0.000982	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NCOA2—breast cancer	5.04e-05	0.000978	CbGpPWpGaD
Flurandrenolide—Betamethasone—ABCB1—breast cancer	5.02e-05	0.0102	CrCbGaD
Flurandrenolide—NR3C1—Adipogenesis—CTNNB1—breast cancer	4.92e-05	0.000954	CbGpPWpGaD
Flurandrenolide—NR3C1—AP-1 transcription factor network—IL6—breast cancer	4.91e-05	0.000953	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—PARP1—breast cancer	4.87e-05	0.000944	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NOTCH3—breast cancer	4.87e-05	0.000944	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—CDKN1A—breast cancer	4.8e-05	0.000932	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—YBX1—breast cancer	4.8e-05	0.000931	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—TP53—breast cancer	4.73e-05	0.000917	CbGpPWpGaD
Flurandrenolide—Hydrocortisone—CYP3A4—breast cancer	4.71e-05	0.00955	CrCbGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—ESR2—breast cancer	4.61e-05	0.000894	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—CXCL8—breast cancer	4.61e-05	0.000894	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—THRB—breast cancer	4.58e-05	0.000888	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—EEF2—breast cancer	4.58e-05	0.000888	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—IL1B—breast cancer	4.42e-05	0.000857	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—CASP3—breast cancer	4.41e-05	0.000855	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—RXRB—breast cancer	4.39e-05	0.000852	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—TET2—breast cancer	4.39e-05	0.000852	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NOTCH2—breast cancer	4.37e-05	0.000847	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—IL6—breast cancer	4.33e-05	0.00084	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—RPL31—breast cancer	4.31e-05	0.000835	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—STAT3—breast cancer	4.29e-05	0.000832	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—JUN—breast cancer	4.28e-05	0.000831	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—breast cancer	4.25e-05	0.000825	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NCOA1—breast cancer	4.25e-05	0.000824	CbGpPWpGaD
Flurandrenolide—Dexamethasone—CYP2D6—breast cancer	4.09e-05	0.0083	CrCbGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—AR—breast cancer	4.07e-05	0.00079	CbGpPWpGaD
Flurandrenolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—breast cancer	4.03e-05	0.000782	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—RPS4X—breast cancer	4.02e-05	0.000779	CbGpPWpGaD
Flurandrenolide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—breast cancer	3.99e-05	0.000775	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—TGFB1—breast cancer	3.97e-05	0.000771	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—EIF3A—breast cancer	3.95e-05	0.000767	CbGpPWpGaD
Flurandrenolide—Hydrocortisone—ABCB1—breast cancer	3.92e-05	0.00795	CrCbGaD
Flurandrenolide—NR3C1—Gene Expression—DNMT3A—breast cancer	3.89e-05	0.000755	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—ELL—breast cancer	3.84e-05	0.000744	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—VEGFA—breast cancer	3.74e-05	0.000726	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—TNF—breast cancer	3.71e-05	0.00072	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—SMAD4—breast cancer	3.67e-05	0.000711	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—VDR—breast cancer	3.66e-05	0.00071	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NCOR1—breast cancer	3.56e-05	0.000691	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—PABPC1—breast cancer	3.55e-05	0.000689	CbGpPWpGaD
Flurandrenolide—Dexamethasone—CYP3A4—breast cancer	3.51e-05	0.00712	CrCbGaD
Flurandrenolide—Dexamethasone—PTGS2—breast cancer	3.43e-05	0.00697	CrCbGaD
Flurandrenolide—NR3C1—Gene Expression—DNMT3B—breast cancer	3.33e-05	0.000645	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—RPL23A—breast cancer	3.26e-05	0.000633	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—TNF—breast cancer	3.21e-05	0.000622	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—HIST1H2BC—breast cancer	3.2e-05	0.000621	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—HIST1H2BK—breast cancer	3.2e-05	0.000621	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—RARB—breast cancer	3.17e-05	0.000616	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—RPS8—breast cancer	3.04e-05	0.00059	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—RPS7—breast cancer	3.04e-05	0.00059	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—MED12—breast cancer	3.04e-05	0.00059	CbGpPWpGaD
Flurandrenolide—NR3C1—Adipogenesis—IL6—breast cancer	2.99e-05	0.000581	CbGpPWpGaD
Flurandrenolide—Dexamethasone—ABCB1—breast cancer	2.92e-05	0.00593	CrCbGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—ESR1—breast cancer	2.8e-05	0.000542	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—NOTCH4—breast cancer	2.76e-05	0.000535	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—NOTCH1—breast cancer	2.7e-05	0.000524	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—HSPA1B—breast cancer	2.63e-05	0.00051	CbGpPWpGaD
Flurandrenolide—NR3C1—SIDS Susceptibility Pathways—IL6—breast cancer	2.59e-05	0.000502	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—PGR—breast cancer	2.52e-05	0.000489	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—DNMT1—breast cancer	2.47e-05	0.00048	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—NCOA2—breast cancer	2.43e-05	0.000471	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—EZH2—breast cancer	2.39e-05	0.000465	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—NOTCH3—breast cancer	2.34e-05	0.000455	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—PARP1—breast cancer	2.34e-05	0.000455	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—SERPINE1—breast cancer	2.3e-05	0.000446	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—RPS6—breast cancer	2.29e-05	0.000444	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—ESR2—breast cancer	2.22e-05	0.000431	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—NOTCH2—breast cancer	2.1e-05	0.000408	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—NCOA1—breast cancer	2.05e-05	0.000397	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—AR—breast cancer	1.96e-05	0.00038	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—SIRT1—breast cancer	1.79e-05	0.000347	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—SMAD4—breast cancer	1.77e-05	0.000342	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—VDR—breast cancer	1.76e-05	0.000342	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—NCOR1—breast cancer	1.71e-05	0.000332	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—H2AFX—breast cancer	1.67e-05	0.000324	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—ERCC2—breast cancer	1.61e-05	0.000313	CbGpPWpGaD
Flurandrenolide—NR3C1—Generic Transcription Pathway—MYC—breast cancer	1.45e-05	0.000282	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—ESR1—breast cancer	1.35e-05	0.000261	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—NOTCH1—breast cancer	1.3e-05	0.000252	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—SERPINE1—breast cancer	1.11e-05	0.000215	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—MAPK3—breast cancer	7.2e-06	0.00014	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—MYC—breast cancer	7e-06	0.000136	CbGpPWpGaD
Flurandrenolide—NR3C1—Gene Expression—AKT1—breast cancer	4.86e-06	9.42e-05	CbGpPWpGaD
